Sight Sciences, Inc. income statement

In fiscal 2025, Sight Sciences, Inc. reported revenue of $77.4m, down 3.1% on the year before, operating income of −$37.1m (a -48.0% margin) and net income of −$38.4m, or −$0.74 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sight Sciences, Inc.: income statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	28	49	71	81	80	77	83
Cost of revenue	9	9	12	12	12	11	10
Gross profit	18	40	59	69	68	67	73
Research and development	9	16	23	18	18	15	11
Selling, general and administrative	42	76	120	109	101	89	90
Operating income	−32	−51	−84	−57	−51	−37	−28
Interest expense	2	4	4	5	5	5	5
Income before tax	−35	−63	−86	−55	−51	−38	−30
Income tax	0	0	0	0	0	0	−0
Net income	−35	−63	−86	−56	−52	−38	−30
Diluted EPS	−$1.24	−$2.36	−$1.80	−$1.14	−$1.03	−$0.74	−$0.56
Diluted shares (average)	28m	27m	48m	49m	50m	52m	53m
EBITDA	−32	−51	−83	−57	−50	−37	−27

US$ millions unless shown otherwise. Fiscal quarters.

Sight Sciences, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	20	19	18	20	20	20	20	23
Cost of revenue	3	3	2	3	3	3	3	2
Gross profit	17	17	15	17	17	18	17	21
Research and development	5	4	4	4	3	2	3	3
Selling, general and administrative	23	24	25	24	22	19	27	23
Operating income	−11	−12	−14	−12	−8	−4	−12	−4
Interest expense	1	1	1	1	1	1	1	1
Income before tax	−11	−12	−14	−12	−8	−4	−13	−4
Income tax	0	0	0	0	−0	0	0	0
Net income	−11	−12	−14	−12	−8	−4	−13	−4
Diluted EPS	−$0.22	−$0.24	−$0.28	−$0.23	−$0.16	−$0.08	−$0.24	−$0.08
EBITDA	−11	−12	−14	−12	−8	−4	−12	−4

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: SGHT vs TELA PDEX vs SGHT LUNG vs SGHT IRMD vs SGHT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sight Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sight Sciences, Inc.